NR3C1 and cancer: To determine whether dexamethasone has anti-CSC activities, we used CSC lines from cancer types in which glucocorticoid receptor (GR) expression has been verified but the therapeutic efficacy of dexamethasone had yet to be demonstrated (21, 22, 23, 24, 25).